OSPN OneSpan Inc.

Nasdaq onespan.com


$ 12.32 $ 0.00 (0 %)    

Tuesday, 04-Nov-2025 04:00:01 EST
QQQ $ 623.05 $ 0.00 (0 %)
DIA $ 469.67 $ 0.00 (0 %)
SPY $ 675.83 $ 0.00 (0 %)
TLT $ 89.94 $ 0.00 (0 %)
GLD $ 367.39 $ 0.00 (0 %)
$ 12.34
$ 11.38
$ 11.06 x 13
$ 12.37 x 332
-- - --
$ 11.00 - $ 20.04
1,479,877
na
469.25M
$ 1.29
$ 8.07
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 03-06-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 02-22-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-16-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 03-15-2019 12-31-2018 10-K
29 11-02-2018 09-30-2018 10-Q
30 08-03-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-08-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 03-10-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 da-davidson-maintains-neutral-on-onespan-lowers-price-target-to-13

DA Davidson analyst Rudy Kessinger maintains OneSpan (NASDAQ:OSPN) with a Neutral and lowers the price target from $15 to $13.

 rosenblatt-maintains-buy-on-onespan-lowers-price-target-to-15

Rosenblatt analyst Catharine Trebnick maintains OneSpan (NASDAQ:OSPN) with a Buy and lowers the price target from $17 to $15.

 onespan-lowers-fy2025-sales-guidance-from-245000m-251000m-to-239000m-241000m-vs-247877m-est

OneSpan (NASDAQ:OSPN) lowers FY2025 sales outlook from $245.000 million-$251.000 million to $239.000 million-$241.000 million v...

 onespan-q3-adj-eps-033-beats-029-estimate-sales-57056m-miss-58181m-estimate

OneSpan (NASDAQ:OSPN) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.29 by 14.5...

 b-riley-securities-initiates-coverage-on-onespan-with-buy-rating-announces-price-target-of-23

B. Riley Securities analyst Erik Suppiger initiates coverage on OneSpan (NASDAQ:OSPN) with a Buy rating and announces Price ...

 rosenblatt-maintains-buy-on-onespan-lowers-price-target-to-17

Rosenblatt analyst Catharine Trebnick maintains OneSpan (NASDAQ:OSPN) with a Buy and lowers the price target from $20 to $17.

 onespan-affirms-fy2025-sales-guidance-of-245000m-251000m-vs-248499m-est

OneSpan (NASDAQ:OSPN) affirms FY2025 sales outlook from $245.000 million-$251.000 million to $245.000 million-$251.000 million ...

 onespan-q2-adj-eps-034-beats-029-estimate-sales-59843m-beat-59046m-estimate

OneSpan (NASDAQ:OSPN) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.29 by 16.0...

 onespan-acquires-nok-nok-labs-terms-undisclosed

Acquisition strengthens OneSpan's commitment to powerful, flexible authentication solutionsOneSpan Inc. (NASDAQ:OSPN) today...

 rosenblatt-maintains-buy-on-onespan-maintains-20-price-target

Rosenblatt analyst Catharine Trebnick maintains OneSpan (NASDAQ:OSPN) with a Buy and maintains $20 price target.

 onespan-affirms-fy2025-sales-guidance-of-24500m-25100m-vs-24868m-est

OneSpan (NASDAQ:OSPN) affirms FY2025 sales outlook from $245.00 million-$251.00 million to $245.00 million-$251.00 million vs $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION